We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Labeling Issue Holds Up Launch of Hospira’s Taxotere ANDA
Labeling Issue Holds Up Launch of Hospira’s Taxotere ANDA
December 7, 2010
Final approval of Hospira’s ANDA for a generic version of Sanofi-Aventis’s oncologic Taxotere is being held up due to a labeling issue.